Fc-engineered anti-CD9 antibodies with reducing platelet toxicity and efficacy against acute lymphoblastic leukemia.
Year: 2025
Type: article
Source: Journal of Clinical Oncology
Authors: Qi Zhao, Shengyu Fu, Wing-Hei Ng, Kam-Tong Leung
Institutions: University of Macau, Chinese University of Hong Kong
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410804455